These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35815617)

  • 81. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials.
    Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ
    Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Spanish Consensus on the Use of Intermittently Scanned Continuous Glucose Monitoring in the Management of Patients With Insulin Therapy: The MONITOR Project.
    Ampudia-Blasco FJ; Ugarte-Abasolo E; Chico A; García-Alemán J; Galan-Barroso M
    J Diabetes Sci Technol; 2023 Sep; 17(5):1256-1264. PubMed ID: 35466722
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Accuracy of intermittently scanned continuous glucose monitoring during caesarean delivery in pregnant women with insulin-treated diabetes.
    Citro F; Bianchi C; Aragona M; Belcari T; Battini L; Marchetti P; Bertolotto A
    Diabetes Res Clin Pract; 2024 Apr; 210():111611. PubMed ID: 38479448
    [TBL] [Abstract][Full Text] [Related]  

  • 84. IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE): A randomized controlled trial.
    Aronson R; Brown RE; Chu L; Bajaj HS; Khandwala H; Abitbol A; Malakieh N; Goldenberg R
    Diabetes Obes Metab; 2023 Apr; 25(4):1024-1031. PubMed ID: 36546594
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Fear of hypoglycemia and quality of life in young people with type 1 diabetes and their parents in the era of sensor glucose monitoring.
    Glocker V; Bachmann S; Hess M; Szinnai G; Burckhardt MA
    Front Endocrinol (Lausanne); 2022; 13():958671. PubMed ID: 35966066
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study
    Préau Y; Galie S; Schaepelynck P; Armand M; Raccah D
    Sensors (Basel); 2021 Sep; 21(18):. PubMed ID: 34577338
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Glucose Profiles Assessed by Intermittently Scanned Continuous Glucose Monitoring System during the Perioperative Period of Metabolic Surgery.
    Kim K; Choi SH; Jang HC; Park YS; Oh TJ
    Diabetes Metab J; 2022 Sep; 46(5):713-721. PubMed ID: 35067012
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes.
    Leelarathna L; Evans ML; Neupane S; Rayman G; Lumley S; Cranston I; Narendran P; Barnard-Kelly K; Sutton CJ; Elliott RA; Taxiarchi VP; Gkountouras G; Burns M; Mubita W; Kanumilli N; Camm M; Thabit H; Wilmot EG;
    N Engl J Med; 2022 Oct; 387(16):1477-1487. PubMed ID: 36198143
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain.
    Conget I; Martín-Vaquero P; Roze S; Elías I; Pineda C; Álvarez M; Delbaere A; Ampudia-Blasco FJ
    Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(7):380-386. PubMed ID: 29789227
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Long-term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration.
    Piona C; Marigliano M; Mozzillo E; Franzese A; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
    Pediatr Diabetes; 2020 Dec; 21(8):1485-1492. PubMed ID: 32935887
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cost-effectiveness of continuous subcutaneous insulin infusion in people with type 2 diabetes in the Netherlands.
    Roze S; Duteil E; Smith-Palmer J; de Portu S; Valentine W; de Brouwer BF; Reznik Y; de Valk HW
    J Med Econ; 2016 Aug; 19(8):742-9. PubMed ID: 26985982
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark.
    Roze S; de Portu S; Smith-Palmer J; Delbaere A; Valentine W; Ridderstråle M
    Diabetes Res Clin Pract; 2017 Jun; 128():6-14. PubMed ID: 28432898
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Exploring the inter-subject variability in the relationship between glucose monitoring metrics and glycated hemoglobin for pediatric patients with type 1 diabetes.
    Bosoni P; Calcaterra V; Tibollo V; Malovini A; Zuccotti G; Mameli C; Sacchi L; Bellazzi R; Larizza C
    J Pediatr Endocrinol Metab; 2021 May; 34(5):619-625. PubMed ID: 33823102
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UK.
    Roze S; Buompensiere MI; Ozdemir Z; de Portu S; Cohen O
    J Med Econ; 2021; 24(1):883-890. PubMed ID: 34098834
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Glycemic Metrics Derived From Intermittently Scanned Continuous Glucose Monitoring.
    Hansen KW; Bibby BM
    J Diabetes Sci Technol; 2022 Jan; 16(1):113-119. PubMed ID: 33269634
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
    Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
    Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: Results From the Randomized Open-label PDF Study.
    Choe HJ; Rhee EJ; Won JC; Park KS; Lee WY; Cho YM
    Diabetes Care; 2022 Oct; 45(10):2224-2230. PubMed ID: 35984640
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The Effect of Do-It-Yourself Real-Time Continuous Glucose Monitoring on Glycemic Variables and Participant-Reported Outcomes in Adults With Type 1 Diabetes: A Randomized Crossover Trial.
    Sehgal S; Elbalshy M; Williman J; Galland B; Crocket H; Hall R; Paul R; Leikis R; de Bock M; Wheeler BJ
    J Diabetes Sci Technol; 2023 Sep; ():19322968231196562. PubMed ID: 37671754
    [TBL] [Abstract][Full Text] [Related]  

  • 99. "Empowering Us": A community-led survey of real-world perspectives of adults with type 1 diabetes using insulin pumps and continuous glucose monitoring to manage their glucose levels.
    Read M; Henshaw KN; Zaharieva DP; Brown TC; Varga AE; Bray C; Cox M; Goody-Rohdin PJ; Hider K; Jelleyman P; Jenkins A; Jones C; Kerr P; Leach R; Martin K; Oreskovic N; O'Sullivan G; Rucioch J; Sims C; Smart C; Speight J; Stanistreet J; Tippett M; Tivalu I; Withers T; O'Neal DN
    Diabetes Res Clin Pract; 2023 Aug; 202():110830. PubMed ID: 37451626
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US.
    Tunis SL; Minshall ME
    Curr Med Res Opin; 2010 Jan; 26(1):151-62. PubMed ID: 19919376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.